Chain drug executives who had a big impact in 2011
or, at the least, not easily forgotten. Here, in no particular order, are 10 chain drug industry executives who made a big impact during 2011: • Greg Wasson, Walgreens’ president and CEO.
Issue 01-02-2012
CDR Retailer of the Year award goes to Walgreens
The editors of Chain Drug Review have named the employees of Walgreen Co. — and more particularly, five of the company’s top executives — as the publication’s 2011 Chain Drug Retailers of the Year.
2012 Retail Forecast: Chain drug eyes broader role
Though uncertainty still surrounds the economy and the U.S. health care reform law, North American drug chains have carved out a role as wellness providers.
Holiday sales a disappointment for drug chains
Absent the last-minute shopping surge that rescued holiday sales a year ago, Christmas 2011 was in the main a dismal event for the nation’s drug chains.
‘Integration sweet spots’ bode well for CVS
CVS Caremark Corp. is capitalizing on its “integration sweet spots” to drive growth.
Concerns raised about impact of PBM merger
The National Association of Chain Drug Stores wants to ensure that Congress has the facts straight regarding the planned merger of Express Scripts Inc. and Medco Health Solutions Inc. In a letter to Sen. Herb Kohl (D., Wis.
Rite Aid augments wellness+ loyalty program
Rite Aid Corp. has expanded its wellness+ customer loyalty program. Executives say the revamped program, which went into effect this month, will deliver more value to customers.
Duane Reade stays on the cutting edge
Extending the horizons of its innovative 40 Wall St. store, Duane Reade has opened a midtown Manhattan drug store with still more novel food and beauty care offerings. The 20,000-square-foot store at 52nd Street and Broadway formerly was a 3,100-square-foot Duane Reade Express outlet.
Pharmacy gains momentum in FUL fight
Community pharmacy advocates say concerns by 40 members of Congress that proposed Medicaid reimbursement rates are inadequate could eventually lead to changes in the plan.
Watts leaves Walgreens
Walgreen Co. corporate vice president and chief innovation officer Colin Watts has left the chain to join Weight Watchers International Inc. as senior vice president of wellness and global innovation.
Medicine Shoppe says suit is without merit
About 60 Medicine Shoppe International (MSI) and Medicap pharmacy owners have filed an arbitration claim against their franchisors alleging lack of support. The franchisees announced their breach-of-contract claim last month. Cardinal Health Inc.
Hy-Vee’s Jurgens set to step down in June
Hy-Vee chairman and chief executive officer Ric Jurgens says he will retire in June. At Hy-Vee’s annual meeting last month, the 62-year-old Jurgens said he feels that the chain, which operates more than 200 food and pharmacy stores and about 25 stand-alone drug stores, has reached the point where he
New reality for community pharmacy in Canada
Community pharmacy in Canada is grappling with a new reality as payers strive to limit drug expenditures and other health care costs while opportunities open up for pharmacists to deliver new, remunerated services.
Mobile shopping options grow at CVS
With a recent study from IBM showing the percentage of consumers using mobile devices to shop has nearly tripled over the past year, CVS/pharmacy has made its entire cvs.com catalog available through its mobile site.
Cosby looks to be good fit at CVS/pharmacy
Mark Cosby made his first public appearance as CVS/pharmacy president last month during CVS Caremark’s 2011 conference for investors and financial analysts.
Outlook for biopharmaceutical sector is bright
patent cliffs, stagnant pipelines, the end of the blockbuster era, etc. In reality, the prospects of the biopharmaceutical sector — for patients in search of new medicines, for policy makers seeking value in the health care system and for